Veto on vedolizumab (MLN0002) for Crohn's disease.
Baumgart
Daniel C
DC
Department of Medicine, Division of Gastroenterology and Hepatology, Charité Medical Center, Virchow Hospital, Medical School of the Humboldt, University of Berlin, Berlin, Germany.